Skip to main content
OpenTrials

Clinical trial condition

Cystadenocarcinoma, Serous

Explore clinical trials studying Cystadenocarcinoma, Serous. Study availability and eligibility vary by location and protocol.

9 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Cystadenocarcinoma, Serous trial results

Completed

A Study of Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma

NCT04814108

Conditions
Adenocarcinoma, Carcinoma, Cystadenocarcinoma, +6 more
Locations
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Honor Health Phoenix, Arizona, United States
  • Arizona Oncology Associates Wilmot HOPE Tucson, Arizona, United States
  • Banner University Medical Center Tucson Tucson, Arizona, United States
View all 56 locations
View Trial Details
Completed

Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer

NCT02101788

Conditions
Adenocarcinoma, Borderline Ovarian Serous Tumor, Carcinoma, +11 more
Locations
  • Tennessee Valley Gynecologic Oncology Huntsville, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 501 locations
View Trial Details
Completed

Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer

NCT00551070

Conditions
Adenocarcinoma, Borderline Ovarian Serous Tumor, Carcinoma, +11 more
Locations
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • Hartford Hospital Hartford, Connecticut, United States
  • The Hospital of Central Connecticut New Britain, Connecticut, United States
View all 49 locations
View Trial Details
Active, Not Recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

NCT02834013

Conditions
Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
View all 1007 locations
View Trial Details
Active, Not Recruiting

Ribociclib and Letrozole Treatment in Ovarian Cancer

NCT03673124

Conditions
Adenocarcinoma, Carcinoma, Cystadenocarcinoma, +6 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • UF Heath Gainesville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northside Hospital Atlanta, Georgia, United States
View all 27 locations
View Trial Details

Related conditions